Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 8/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | HTR2A | P28223 | 6/20 | 0.48 |
| ▸ | HTR2C | P28335 | 3/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7368300 | 0.92 | DRD2 (0.50) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7370354 | 0.91 | DRD2 (0.52) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7365738 | 0.90 | DRD2 (0.51) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7366540 | 0.88 | DRD2 (0.50) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7364405 | 0.88 | DRD2 (0.49) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7360762 | 0.87 | DRD2 (0.51) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7366170 | 0.85 | HTR6 (0.53) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7368733 | 0.84 | DRD2 (0.53) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7365706 | 0.84 | DRD2 (0.55) | DRD2SLC6A4ACHEHTR2AHTR2C | |
| SCHEMBL7367433 | 0.84 | DRD2 (0.55) | DRD2SLC6A4ACHEHTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5780474-A | ADMINISTERING IN THE TREATMENT OF PSYCHOTIC DISORDERS, ANXIO-DEPRESSIVE DISORDERS AND AGGRESSIVENESS | ADIR ET COMPAGNIE (FR) | 1998-07-14 | — | — | US | claimed |
| US-5780474-A | ADMINISTERING IN THE TREATMENT OF PSYCHOTIC DISORDERS, ANXIO-DEPRESSIVE DISORDERS AND AGGRESSIVENESS | ADIR ET COMPAGNIE (FR) | 1998-07-14 | — | — | US | disclosed |